Improving T cell killing and understanding senescence: Possible roles for TP53 in cancer immunotherapy
Author:
Affiliation:
1. Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ 08540
Publisher
Proceedings of the National Academy of Sciences
Link
https://pnas.org/doi/pdf/10.1073/pnas.2402533121
Reference11 articles.
1. Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α
2. p53: 800 million years of evolution and 40 years of discovery
3. The Isoforms of the p53 Protein
4. P53 and The Immune Response: 40 Years of Exploration—A Plan for the Future
5. Δ133p53: A p53 isoform enriched in human pluripotent stem cells
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding the complexity of p53 in a new era of tumor suppression;Cancer Cell;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3